Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 13, 2026

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
05:52

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy

Published on: August 19, 2021

[Sentinel node identification in cervical cancer patients: a feasibility study].

Dariusz Wydra1, Sambor Sawicki, Janusz Emerich

  • 1Katedra i Klinika Ginekologii i Ginekologii Onkologicznej AM w Gdańsku. dwydra@amg.gda.pl

Ginekologia Polska
|July 27, 2007
PubMed
Summary

Sentinel node (SN) mapping is feasible for early-stage cervical cancer, offering reduced morbidity. This technique aids treatment decisions, potentially avoiding radical surgery and lowering complications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Laparoscopy and laparotomy in endometrial cancer - a meta-analysis.

Archives of medical science : AMS·2026
Same author

Prenatal ultrasonography diagnosis of urinary tract duplication in female fetus.

Ginekologia polska·2026
Same author

Role of Ultrasound and Fetal MRI in the Prenatal Assessment of Congenital Cytomegalovirus Infection: A Systematic Review.

Journal of clinical medicine·2026
Same author

Navigating hypertriglyceridemia in pregnancy: current evidence and clinical strategies.

Frontiers in endocrinology·2026
Same author

Preeclampsia: Contemporary Concepts in Pathophysiology, Risk Stratification, Prevention and Monitoring.

Journal of clinical medicine·2026
Same author

Alterations in lipid metabolism and blood profile in gynecological cancers - potential strategies in diagnosis and treatment.

Frontiers in physiology·2026

Area of Science:

  • Gynecologic Oncology
  • Surgical Pathology
  • Nuclear Medicine Imaging

Background:

  • Sentinel node (SN) biopsy is recommended to reduce overtreatment and morbidity in early-stage cervical cancer.
  • Accurate SN identification is crucial for staging and treatment planning.

Purpose of the Study:

  • To assess the feasibility of sentinel lymph node identification using radioisotopic lymphatic mapping and blue dye injection.
  • To evaluate SN detection rates in patients with early-stage cervical cancer.

Main Methods:

  • Radioisotopic lymphatic mapping with technetium-99m labelled nanocolloid and blue dye injection.
  • Investigated 100 patients with FIGO stage IB1 to IIA primary cervical carcinoma.
  • Pelvic lymphadenectomy was performed in conjunction with radical hysterectomy.

More Related Videos

Multispectral Real-time Fluorescence Imaging for Intraoperative Detection of the Sentinel Lymph Node in Gynecologic Oncology
06:37

Multispectral Real-time Fluorescence Imaging for Intraoperative Detection of the Sentinel Lymph Node in Gynecologic Oncology

Published on: October 20, 2010

Related Experiment Videos

Last Updated: Jul 13, 2026

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
05:52

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy

Published on: August 19, 2021

Multispectral Real-time Fluorescence Imaging for Intraoperative Detection of the Sentinel Lymph Node in Gynecologic Oncology
06:37

Multispectral Real-time Fluorescence Imaging for Intraoperative Detection of the Sentinel Lymph Node in Gynecologic Oncology

Published on: October 20, 2010

Main Results:

  • Sentinel node detection rates were 96.6% for stage IB1, 66.7% for IB2, and 62.5% for IIA.
  • Successful SN identification was lower in tumors >2cm (54%) compared to tumors ≤2cm (96%).
  • The false-negative rate for the SN procedure was 3%, with sensitivity of 86.4% and specificity of 100%.

Conclusions:

  • Sentinel node mapping is a feasible and effective method for early-stage cervical cancer patients.
  • SN detection rates are influenced by FIGO stage and tumor size.
  • SN mapping can guide treatment decisions, potentially enabling less radical approaches like radiochemotherapy and reducing postoperative complications.